{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:49:09Z","timestamp":1783784949116,"version":"3.55.0"},"reference-count":29,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0325","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T22:06:41Z","timestamp":1605910001000},"page":"399-407","source":"Crossref","is-referenced-by-count":12,"title":["Metreleptin worked in a diabetic woman with a history of hematopoietic stem cell transplantation (HSCT) during infancy: further support for the concept of \u2018HSCT-associated lipodystrophy\u2019"],"prefix":"10.1507","volume":"68","author":[{"given":"Masanori","family":"Adachi","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama 232-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Muroya","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama 232-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hanakawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama 232-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Asakura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama 232-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Freycon F, Casagranda L, Trombert-Paviot B (2019) The impact of severe late-effects after 12\u2009Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988\u20132010). Pediatr Hematol Oncol 36: 86\u2013102.","DOI":"10.1080\/08880018.2019.1591549"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Nakagawa R, Hosokawa-Tsuji A, Aoki Y, Takasawa K, Maru M, et al. (2018) Total body irradiation for hematopoietic stem cell transplantation during early childhood is associated with the risk for diabetes mellitus. Endocrine 61: 76\u201382.","DOI":"10.1007\/s12020-018-1595-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Wei C, Hunt L, Cox R, Bradley K, Elson R, et al. (2017) Identifying cardiovascular risk in survivors of childhood leukaemia treated with haematopoietic stem cell transplantation and total body irradiation. Horm Res Paediatr 87: 116\u2013122.","DOI":"10.1159\/000455046"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Tomita Y, Ishiguro H, Yasuda Y, Hyodo H, Koike T, et al. (2011) High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT. Bone Marrow Transplant 46: 416\u2013425.","DOI":"10.1038\/bmt.2010.144"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Lorenc A, Hamilton-Shield J, Perry R, Stevens M (2020) Body composition after allogeneic haematopoietic cell transplantation\/total body irradiation in children and young people: a restricted systematic review. J Cancer Surviv 14: 624\u2013642.","DOI":"10.1007\/s11764-020-00871-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Wei C, Thyagiarajan MS, Hunt LP, Shield JP, Stevens MC, et al. (2015) Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes. Pediatr Blood Cancer 62: 1992\u20131999.","DOI":"10.1002\/pbc.25601"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Adachi M, Oto Y, Muroya K, Hanakawa J, Asakura Y, et al. (2017) Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey. Clin Pediatr Endocrinol 26: 99\u2013108.","DOI":"10.1297\/cpe.26.99"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Adachi M, Asakura Y, Muroya K, Goto H, Kigasawa H (2013) Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy. Clin Pediatr Endocrinol 22: 53\u201364.","DOI":"10.1297\/cpe.22.53"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ceccarini G, Ferrari F, Santini F (2017) Acquired partial lipodystrophy after bone marrow transplant during childhood: a novel syndrome to be added to the disease classification list. J Endocrinol Invest 40: 1273\u20131274.","DOI":"10.1007\/s40618-017-0731-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Rooney DP, Ryan MF (2006) Diabetes with partial lipodystrophy following sclerodermatous chronic graft <i>vs.<\/i> host disease. Diabet Med 23: 436\u2013440.","DOI":"10.1111\/j.1464-5491.2006.01855.x"},{"key":"11","unstructured":"11 Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, et al. (2012) Report of the committee on the classification and diagnostic criteria of diabetes mellitus: revision for international harmonization of HbA1c in Japan. J Jpn Diabet Soc 55: 485\u2013504 (In Japanese)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Fiorenza CG, Chou SH, Mantzoros CS (2011) Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol 7: 137\u2013150.","DOI":"10.1038\/nrendo.2010.199"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Chan JL, Lutz K, Cochran E, Huang W, Peters Y, et al. (2011) Clinical effects of long-term metreleptin treatment in patients with lipodystrophy. Endocr Pract 17: 922\u2013932.","DOI":"10.4158\/EP11229.OR"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Oral EA, Gorden P, Cochran E, Ara\u00fajo-Vilar D, Savage DB, et al. (2019) Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy. Endocrine 64: 500\u2013511.","DOI":"10.1007\/s12020-019-01862-8"},{"key":"15","unstructured":"15 Ajluni N, Dar M, Xu J, Neidert AH, Oral EA (2016) Efficacy and safety of metreleptin in patients with partial lipodystrophy: lessons from an expanded access program. J Diabetes Metab 7: 659."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Beltrand J, Lahlou N, Le Charpentier T, Sebag G, Leka S, et al. (2010) Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin. Eur J Endocrinol 162: 1083\u20131091.","DOI":"10.1530\/EJE-09-1027"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Chan JL, Koda J, Heilig JS, Cochran EK, Gorden P, et al. (2016) Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy. Clin Endocrinol (Oxf) 85: 137\u2013149.","DOI":"10.1111\/cen.12980"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, et al. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110: 1093\u20131103.","DOI":"10.1172\/JCI0215693"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Mahlangu JN, Weldingh KN, Lentz SR, Kaicker S, Karim FA, et al. (2015) Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity. J Thromb Haemost 13: 1989\u20131998.","DOI":"10.1111\/jth.13141"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 van Schouwenburg PA, Krieckaert CL, Rispens T, Aarden L, Wolbink GJ, et al. (2013) Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation. Ann Rheum Dis 72: 1680\u20131686.","DOI":"10.1136\/annrheumdis-2012-202407"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Ungar B, Chowers Y, Yavzori M, Picard O, Fudim E, et al. (2014) The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab. Gut 63: 1258\u20131264.","DOI":"10.1136\/gutjnl-2013-305259"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Nagayama A, Ashida K, Moritaka K, Hidaka M, Gobaru M, et al. (2019) Metreleptin supplementation for improving lipid and glycemic profiles in acquired diabetes lipodystrophy: a case report. J Endocr Soc 3: 2179\u20132183.","DOI":"10.1210\/js.2019-00251"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Shibata Y, Nakatsuka A, Eguchi J, Miyamoto S, Masuda Y, et al. (2018) Acquired partial lipoatrophy as graft-<i>versus<\/i>-host disease and treatment with metreleptin: two case reports. J Med Case Rep 12: 368.","DOI":"10.1186\/s13256-018-1901-y"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Rajendran R, Abu E, Fadl A, Byrne CD (2013) Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation. Diabet Med 30: e239\u2013e242.","DOI":"10.1111\/dme.12234"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Mayson SE, Parker VE, Schutta MH, Semple RK, Rickels MR (2013) Severe insulin resistance and hypertriglyceridemia after childhood total body irradiation. Endocr Pract 19: 51\u201358.","DOI":"10.4158\/EP12115.OR"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Bizzarri C, Pinto RM, Ciccone S, Brescia LP, Locatelli F, et al. (2015) Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation. Pediatr Blood Cancer 62: 1650\u20131655.","DOI":"10.1002\/pbc.25603"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Pluimakers VG, van Waas M, Neggers SJCMM, van den Heuvel-Eibrink MM (2019) Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors. Crit Rev Oncol Hematol 133: 129\u2013141.","DOI":"10.1016\/j.critrevonc.2018.10.010"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 M\u00f8ller N, J\u00f8rgensen JO (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30: 152\u2013177.","DOI":"10.1210\/er.2008-0027"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Oudin C, Auquier P, Bertrand Y, Contet A, Kanold J, et al. (2015) Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study. Bone Marrow Transplant 50: 1438\u20131444.","DOI":"10.1038\/bmt.2015.167"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/4\/68_EJ20-0325\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T03:28:46Z","timestamp":1619839726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/4\/68_EJ20-0325\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0325","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}